Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 83Pancreatic Neoplasms 26Esophageal Squamous Cell Carcinoma 10Esophageal Neoplasms 10Biliary Tract Neoplasms 10Colorectal Neoplasms 9Neoplasm Metastasis 7Nasopharyngeal Carcinoma 5Cholangiocarcinoma 5Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Recurrence 3Head and Neck Neoplasms 3Advanced Pancreatic Cancer 3Rectal Neoplasms 2NSCLC 2Locally Advanced Pancreatic Cancer 2Gastrointestinal Neoplasms 2Gastric Cancer Peritoneal Metastases 2Advanced Non-Small Cell Lung Cancer 2Advanced Gastric Cancer 2Adenocarcinoma 2mCRC 1Surgically-Created Resection Cavity 1Stage IV Gastric Cancer With Metastasis 1Squamous Cell Carcinoma of Head and Neck 1Progression Free Survival 1Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Pancreatic cancer, adult 1Pancreatic Ductal Adenocarcinoma 1

Interventions

Fluorouracil 87Leucovorin 78Oxaliplatin 77Irinotecan 76Bevacizumab 50Cetuximab 42Capecitabine 42Panitumumab 17Folfox protocol 16Floxuridine 11Chemotherapy, Adjuvant 11regorafenib 10IFL protocol 10Nivolumab 9Drug Therapy 9trifluridine tipiracil drug combination 8Surgical Procedures, Operative 8Neoadjuvant Therapy 8sargramostim 7pembrolizumab 7XELOX 7Specimen Handling 7Biopsy 7Trastuzumab 6Radiotherapy 6Magnetic Resonance Spectroscopy 6HMPL-013 6tislelizumab 5encorafenib 5Trifluridine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Colonic Neoplasms × S 1 (combination) × Clear all
NCT02216149 2018-08-28

FluoHeart

Helsinki University Central Hospital

Phase 2 Terminated
20 enrolled
Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT02618356 2017-10-02

Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer

Fudan University

Phase 2 Unknown
82 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00569335 2012-11-02

Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer

Taiho Pharmaceutical Co., Ltd.

Phase 2 Completed
52 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00197431 2006-03-22

Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer

Hamamatsu University

Phase 2 Unknown
Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡